Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Thrombophilic gene polymorphism studies in G6PD deficient individuals from Saudi population.

Alharbi KK, Khan IA, Syed R.

Bioinformation. 2012;8(25):1255-9. doi: 10.6026/97320630081255. Epub 2012 Dec 19.

2.

Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.

Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR.

J Pediatr Gastroenterol Nutr. 2002 Nov;35(5):629-35.

PMID:
12454577
3.

Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.

J Vasc Surg. 2005 May;41(5):808-15.

4.

Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.

Ben Salem-Berrabah O, Fekih-Mrissa N, N'siri B, Ben Hamida A, Benammar-Elgaaied A, Gritli N, Mrissa R.

J Clin Neurosci. 2012 Sep;19(9):1326-7. doi: 10.1016/j.jocn.2011.11.029. Epub 2012 Jun 20.

PMID:
22721898
6.

The prevalence of factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T among G6PD deficient individuals from Western Iran.

Mozafari H, Rahimi Z, Heidarpour A, Fallahi M, Muniz A.

Mol Biol Rep. 2009 Nov;36(8):2361-4. doi: 10.1007/s11033-009-9458-x. Epub 2009 Feb 15.

PMID:
19219640
7.
8.

Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.

Rahimi Z, Nomani H, Mozafari H, Vaisi-Raygani A, Madani H, Malek-Khosravi S, Parsian A.

Blood Coagul Fibrinolysis. 2009 Jun;20(4):252-6. doi: 10.1097/MBC.0b013e3283255487.

PMID:
19349859
9.

The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.

Al-Sweedan SA, Jaradat S, Iraqi M, Beshtawi M.

Blood Coagul Fibrinolysis. 2009 Dec;20(8):675-8. doi: 10.1097/MBC.0b013e3283315b4f.

PMID:
19710606
10.

Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.

Yasa MH, Bolaman Z, Yukselen V, Kadikoylu G, Karaoglul AO, Batun S.

Hepatogastroenterology. 2007 Jul-Aug;54(77):1438-42.

PMID:
17708272
11.

Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran.

Bagheri M, Rad IA, Nanbakhsh F.

Arch Gynecol Obstet. 2011 Nov;284(5):1311-5. doi: 10.1007/s00404-011-2008-5. Epub 2011 Jul 20.

PMID:
21773779
12.
13.

MTHFR C677T, FII G20210A, FV Leiden G1691A, NOS3 intron 4 VNTR, and APOE epsilon4 gene polymorphisms are not associated with spontaneous cervical artery dissection.

Jara-Prado A, Alonso ME, Martínez Ruano L, Guerrero Camacho J, Leyva A, López M, Gutierrez-Castrellon P, Arauz A.

Int J Stroke. 2010 Apr;5(2):80-5. doi: 10.1111/j.1747-4949.2010.00412.x.

PMID:
20446941
14.

The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.

Dodson PM, Haynes J, Starczynski J, Farmer J, Shigdar S, Fegan G, Johnson RJ, Fegan C.

Eye (Lond). 2003 Aug;17(6):772-7.

PMID:
12928694
15.

Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs.

Almawi WY, Keleshian SH, Borgi L, Fawaz NA, Abboud N, Mtiraoui N, Mahjoub T.

J Thromb Thrombolysis. 2005 Dec;20(3):163-8.

PMID:
16261289
16.

Molecular characterization of factor V leiden G1691A and prothrombin G20210A mutations in Saudi newborns with stroke.

Gawish GE.

Biochem Genet. 2011 Oct;49(9-10):601-10. doi: 10.1007/s10528-011-9435-7. Epub 2011 Apr 2.

PMID:
21461667
17.

Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.

Mazoyer E, Ripoll L, Gueguen R, Tiret L, Collet JP, dit Sollier CB, Roussi J, Drouet L; FITENAT Study Group.

Blood Coagul Fibrinolysis. 2009 Oct;20(7):503-10. doi: 10.1097/MBC.0b013e32832f5d7a.

PMID:
19730248
18.

[Factor V Leiden (G1691A) and prothrombin-G20210A alleles among patients with deep venous thrombosis and in the general population from Spain].

Francès F, Portolès O, Gabriel F, Corella D, Sorlí JV, Sabater A, Alfonso JL, Guillén M.

Rev Med Chil. 2006 Jan;134(1):13-20. Epub 2006 Mar 8. Spanish.

19.

Factor V G1691A (Leiden) and prothrombin G20210A single-nucleotide polymorphisms in type 2 diabetes mellitus.

Wakim-Ghorayeb SF, Keleshian SH, Timson G, Finan RR, Najm P, Irani-Hakime N, Almawi WY.

Am J Hematol. 2005 Sep;80(1):84-6.

20.

Thrombophilia-related genetic variations in patients with pulmonary embolism in the main teaching hospital in Jordan.

Obeidat NM, Awidi A, Sulaiman NA, Abu-Khader IB.

Saudi Med J. 2009 Jul;30(7):921-5.

PMID:
19618008

Supplemental Content

Support Center